3,4-Dihydroxymandelic acid
|
Basic information |
| Metabolite name | 3,4-Dihydroxymandelic acid |
 | HMDB0001866 |
 |
C05580 |
 |
85782 |
| Synonyms | 3,4-dihydroxymandelate |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | 3,4-Dihydroxymandelic acid |
| HMDB0001866 |
|
C05580 |
|
85782 |
| Synonyms | 3,4-dihydroxymandelate |
| No. of studies | 7 |
|
Relationship between 3,4-Dihydroxymandelic acid and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M036 | Type1 | MDD group vs. control group | Urine | Human | Down |
| Study M037 | Type2 | placebo treatment group one-week vs. baseline | Serum | Human | Up |
| Study M037 | Type2 | sertraline treatment group four-week vs. baseline | Serum | Human | Up |
| Study M058 | Type1 | depressed HBV-infected patients group vs. control group and non-depressed HBV-infected group | Urine | Human | Up |
| Study M1079 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Up |
| Study M948 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Down |